Delivery Order SPE2DB22D2214-SPE2DB24FS5UR

Award Date 7/15/24
Potential Completion Date 7/16/24
Potential Value $5.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the provision of the pharmaceutical product WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The award, valued at $34,970.38, was made by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense (DoD), and does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA). The contract, valued at $1,908.62, is a delivery order issued under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is a single-award IDC valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for...
This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price of $3,486.62 and an ultimate completion date of April 9, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the prescription drug WEGOVY 1 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA). The award, valued at $3,291.24, was made on a firm-fixed price basis without any set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, is for the supply of the medication WEGOVY 1 MG/0.5 ML PEN 0.5ML. The contract, valued at $1,097.08, is a delivery order issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 25, 2024. The contract is a firm fixed-price arrangement, without any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $1,097.08, has an ultimate completion date of April 24, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle for delivering a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,500.59 firm fixed-price delivery order is for the pharmaceutical product WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of December 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order valued at $4,975.31 for the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued up to $999,999,999.00, that serves as...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The award is a Delivery Order with a Firm Fixed Price of $2,171.78, with an ultimate completion date of April 23, 2024. The contracting agency is the Defense Logistics Agency (DLA), which is a defense agency supporting the U.S. Armed Forces and other government agencies. Amerisourcebergen holds a larger Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The award, valued at $1,097.08, is a delivery order placed under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. This single-award IDC, valued up to $999,999,999.00 through December 31, 2025, serves as the primary vehicle for Amerisourcebergen to provide a wide...
  • SPE2DB22D2214
    Indefinite Delivery Contract
  • SPE2DB22D2214-SPE2DB24FS5UR
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML. The award, valued at $5,749.81, was made by the Defense Logistics Agency (DLA) and does not have a set-aside designation.

Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials, to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs through May 2024.

Generated 10/14/24, 10:02 AM